Advarra IRB Chair Luke Gelinas Featured in PRIM&R Blog and Webinar About Complexity in Clinical Trial Design
In June, Advarra IRB Chairperson Luke Gelinas was a guest speaker in a PRIM&R webinar called Complexity in Clinical Trial Design: A Primer on Adaptive and Platform Trials. As a follow-up to that event, Gelinas was recently featured in PRIM&R’s blog Ampersand. This blog outlines the key terms they used in the webinar, explores ethical and regulatory challenges, and provides solutions on how to bridge the gap between IRBs and researchers.
“The effort to find better and more effective therapies for a wide variety of diseases in a more cost-effective manner is one that is endorsed by patients, regulators, the medical community, and drug developers,” according to Gelinas and his co-presenter Marianne Kearney Chase. “Complex clinical trial designs hold much promise in helping to achieve these objectives.”
Public Responsibility in Medicine and Research (PRIM&R) is committed to promoting dialogue and sharing knowledge about issues relevant to research ethics and oversight, in pursuit of our mission to advance the highest ethical standards in the practice of research with human subjects and animals.
PRIM&R’s blog, Ampersand, serves as an outlet for diverse perspectives and a source of information and commentary for the research ethics and oversight community. Through timely, thoughtful pieces on issues relevant to human subject protections and animal care and use, Ampersand invites respectful conversation and debate, creates community, and provides resources for professionals in these fields.